| Rubina Hafeez Khan, MD | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-7518 | |
| Not Available |
| Full Name | Rubina Hafeez Khan |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376770347 | NPI | - | NPPES |
| 1942375 | Medicaid | LA | |
| 01381844 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD.205160 (Louisiana) | Primary |
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Lifestyle-related cardiometabolic risk factors cluster already in children in the same way as in adults, according to research from the University of Eastern Finland. A cardiometabolic risk score was used to evaluate cardiometabolic risk in different age groups.
Heavy drinking alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, and health care and criminal justice expenses.
Many questions remain about what this number means, though, including how many of those enrolling in new coverage had been uninsured before signing up and whether young and healthy people will be adequately represented.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
› Verified 6 days ago
| Entity Name | Belle Chasse Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245653237 PECOS PAC ID: 9335379379 Enrollment ID: O20140313000496 |
News Archive
Lifestyle-related cardiometabolic risk factors cluster already in children in the same way as in adults, according to research from the University of Eastern Finland. A cardiometabolic risk score was used to evaluate cardiometabolic risk in different age groups.
Heavy drinking alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, and health care and criminal justice expenses.
Many questions remain about what this number means, though, including how many of those enrolling in new coverage had been uninsured before signing up and whether young and healthy people will be adequately represented.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rubina Hafeez Khan, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-7518 | Rubina Hafeez Khan, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-7518 |
News Archive
Lifestyle-related cardiometabolic risk factors cluster already in children in the same way as in adults, according to research from the University of Eastern Finland. A cardiometabolic risk score was used to evaluate cardiometabolic risk in different age groups.
Heavy drinking alcohol consumption is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, and health care and criminal justice expenses.
Many questions remain about what this number means, though, including how many of those enrolling in new coverage had been uninsured before signing up and whether young and healthy people will be adequately represented.
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes' proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
› Verified 6 days ago
Dr. Brian Thomas Halbert, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3910 Fax: 504-842-4533 | |
Dr. Diane Davis Van Gerwen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-7518 | |
Robert Lawrence Marier, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Corey Gregg, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2000 Canal St, New Orleans, LA 70112 Phone: 954-551-1683 | |
Dr. Marianne Maumus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Ryan Stephen Kissee, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl 50, New Orleans, LA 70112 Phone: 504-988-7809 Fax: 504-988-3971 | |
Jordan Callender, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Ave, Room 436, New Orleans, LA 70112 Phone: 504-568-7884 |